Creating healthier spaces and safer environments.

Request A Consultation
Until 2020 crises, your employees and your customers didn’t think about antimicrobial protection in public spaces.

Now, both your employees and your customers are very aware of microbes, bacteria, and viruses laying around in unprotected spaces and the dangers that come along with them. People want to know that places where they live, work, learn, and play are putting their health and safety first.

We know how to stop the spread of germs effectively. Our comprehensive Pathogen Defense System offers an integrated approach to hygiene, disinfection, and antimicrobial treatment that protects 24/7 for 120 days.

Unique

System & Approach.

1.

Disinfect.

We use our cutting-edge, EPA approved (List N) solutions to clean and disinfect.
2.

Protect.

Our technology creates a semi-permanent bond with whatever surface it is applied to. As soon as we apply our ClearShield antimicrobial, it begins working 24/7 to protect against unwanted microbials for 120 days.
3.

Maintain.

We provide the Selectrocide disinfectant to clean and disinfect the high touch areas to ensure ClearShield spikes are not clogged by oils and residue left by human skin on contact.

Our System also includes:

  • Application protocols, customized for each location by an Industrial Hygienist
  • Testing protocols for before, during, and after application
  • Subrogation by our insurance policy
  • Training cleaning crew or staff members on proper disinfection procedures
Our standard protocols recommend the application of disinfectant throughout the Air Conditioning and Heating system to improve air quality and reduce the number of pathogens living on the coils and in the duct system.
Home 1

Why Everest InvisaShield

Comprehensive Pathogen Defense System providing disinfection and long-term antimicrobial protection on all treated areas 24/7 for up to 120 days
Testing protocols for before, during and after application
Customized site protocols for each facility developed by an Industrial Hygienist
EPA tested and approved products
Subrogation by our insurance policy
Training of janitorial crew or staff members on proper disinfection procedures to maintain high touch surfaces included
120 protection achieved with implementation of the full Pathogen Defense System and regular usage. Unusually high traffic areas and surfaces with high abrasion have to be treated more often.

Clinical, Peer-Reviewed, and

Other Studies.

This study evaluated a product designed to create a long-lasting surface coating that provides continuous antimicrobial action. The product assessed in this study was found to have persisted over 15 weeks in reducing the total number of bacteria and antibiotic-resistant bacteria on the surface within an ICU. After applying the system in an ICU, cultures were taken at 1, 2, 4, 8, and 15 weeks and average levels of bacteria never returned to pre-treatment levels. This peer-review paper was printed in the American Journal of Infection Control (Issue 42, pages 1178-81). Read the full study now.
Clinical Infectious Diseases, October 2019. Impact of a Novel Antimicrobial Surface Coating on Healthcare-Associated Infections (HAIs) and Environmental Bioburden at Two Urban Hospitals. Statistically significant reductions in HAIs and environmental bioburdens occurred in the units receiving the antimicrobial outcomes and persistent reductions in environmental contamination. Results published in Clinical Infectious Diseases in October 2019. Read the full study now.
This field study was designed to detect changes in environmental and antibiotic resistant bacteria (MRSA) levels before and after application of our system. Surfaces within waiting areas of the participating hospital (including an emergency department) were sampled before treatment for Baseline cultures then sampled e1, 2, 4, 8, and 15 weeks after application of our system. Even in these very high touch-point areas, the system remained highly effective after 8 weeks. Read the full study now.
Public Transit Study The goal of this study was to assess bacterial loads on very high touch point surfaces within municipal buses. Samples were taken in the drivers' compartment, entrance railing, seat backs, interior railing and fare boxes. An overall significant reduction was observed 30 days after treatment in the buses which transported roughly 20,000 passengers per bus during the study. Since this study was conducted in 2014, our process now includes a third protective barrier step which produces greater results as observed in the more resent hospital studies. Read the full public transit study now.
Previous
Next